As of 2026-01-08, the Intrinsic Value of Immunic Inc (IMUX) is -4.28 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.62 USD, the upside of Immunic Inc is -787.03%.
Based on its market price of 0.62 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 787.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.28 - -4.28 | -4.28 | -787.03% |
| P/E | (14.56) - (3.60) | (10.60) | -1800.4% |
| DDM - Stable | (5.61) - (20.58) | (13.10) | -2200.8% |
| DDM - Multi | (0.09) - (0.25) | (0.13) | -120.9% |
| Market Cap (mil) | 74.99 |
| Beta | 0.74 |
| Outstanding shares (mil) | 120.28 |
| Enterprise Value (mil) | 39.86 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.21% |
| Cost of Debt | 5.00% |
| WACC | 7.44% |